The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy. Hatletvedt ND, Engebrethsen C, Geisler J, Geisler S, et al. BMC Cancer 2025;25:308.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hatletvedt ND, Engebrethsen C, Geisler J, Geisler S, et al. The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy. BMC Cancer 2025;25:308.
PMID: 39979836